T. Rowe Price T. Rowe Price Trusty Logo

Price Point - In Brief

U.S. Equities

Finding Alpha in U.S. Large-Cap Growth Stocks

Taymour Tamaddon, Portfolio Manager for the U.S. Equity Division

Executive Summary

  • While about a quarter of the Russell 1000 Growth Index’s total returns during the past five years have come from FAANG stocks, there are significant opportunities for generating alpha away from the dominant tech and consumer discretionary names.
  • Security selection informed by skilled analysis, including field research, can aid a portfolio’s prospects for long‑term outperformance.
  • Apart from using stock‑specific insights, alpha can be generated by understanding sector dynamics and weighting subsectors within a sector appropriately to take advantage of these insights.
  • We regard our ability to regularly revisit an investment thesis as crucial when analyzing the impact of new technology.


The group of large technology and consumer discretionary companies known as the FAANG stocks have dominated headlines in the large‑cap growth equity market in recent years. And, even though they have faced increased volatility in the second half of 2018, this attention has been largely well deserved as the stocks of Facebook, Amazon.com, Apple, Netflix, and Google‑parent Alphabet produced outsized long‑term returns.

However, about three‑quarters of the Russell 1000 Growth Index’s total returns during the past five years have come from non‑FAANG stocks, and we believe there are significant opportunities for generating alpha away from the tech titans. Fundamental research can help investors identify companies that can add diversification to their portfolio along with the potential for outperformance. In this Price Point, we highlight some examples from across a variety of sectors—namely payment providers, health care, software as a service (SaaS), and cloud computing—where possessing deep knowledge of a company or subsector yielded attractive investment ideas.


We believe that a key to being a successful investor is achieving a deep understanding of how companies make money, and our decision to invest in PayPal came from insights into the financial incentives that were driving the actions of several players in the electronic payments industry.

Visa and credit card‑issuing banks such as JPMorgan Chase saw upstart PayPal as a threat, but after we spent a significant amount of time analyzing the businesses of Visa, JPMorgan, and PayPal, we saw there was room for these companies to work together profitably. PayPal originally only allowed its customers to make payments from a bank account, but we realized the company—along with Visa and JPMorgan—could benefit if it allowed customers to link their payments to a credit card. This gave us confidence that PayPal had a growth opportunity in front of it.

After PayPal started to offer the credit card option, new customer sign‑ups accelerated. Although earnings took a slight hit initially from the higher expenses of processing credit card transactions, the growing customer base drove PayPal’s price/earnings multiple higher than we expected.


Apart from using stock‑specific insights, a powerful way to drive alpha is understanding what is occurring in a sector and weighting subsectors within a sector appropriately to take advantage of these insights. This theme has informed our approach to health care.

It wasn’t long ago that biotechnology companies experienced a golden era as advances in genetics contributed to successes in the development of new treatment options. However, biotechs started to face headwinds in 2015 as their product pipelines shrank and pricing and regulatory pressures increased. At the same time, we saw positive developments occurring in the equipment and supplies and provider segments. We shifted from an overweight to an underweight in biotech as we expanded our allocation to more promising health care subsectors.

Over the three years ended in June 2018, equipment and supplies was the strongest segment within the Russell 1000 Growth Index’s health care sector, with a 96% gain, while biotech was the weakest segment, declining 19%.

Figure 1: Software as a Service Market Growth

As of April 30, 2018

Source: Gartner


Our investment in ServiceNow is an example of how being able to follow a company as it develops can generate alpha. Our firm’s mid‑cap franchise had owned ServiceNow for more than three years before the company grew big enough for it to be considered for our large‑cap portfolio.

The insights we received during this period made us comfortable adding it to our portfolio as we saw the benefits of the software as a service business model (see Figure 1). Charging clients annually for services is a less volatile business than selling software products one at a time, which was the old way of operating. But the real benefit is that these companies were able to innovate at a much more rapid rate than their traditional competitors, who often had one big product rollout but then struggled. With the software as a service business model, ServiceNow has continued to succeed in its second and third acts.


A final example of how we generate alpha involves cloud computing and shows the importance of revisiting an investment thesis when necessary. In 2015, our internal research suggested that businesses would quickly make a complete transition to the cloud and away from maintaining their own tech infrastructure. And, in fact, we did see a significant migration over the next couple of years. But, as we started to talk to enterprise IT managers about how they were using the cloud and visited their firms to deepen our understanding, we realized the story was a little more nuanced.

The IT managers told us that, even though they were building their new work processes to benefit from the public cloud, they didn’t see a financial benefit to transitioning all of their legacy workloads. This shift in tone prompted us to take a fresh look at companies, including Red Hat and VMware, which the market had left for dead based on projections that Amazon was going to completely own the space. Our analysis led us to conclude that they had a vibrant future, and we purchased both Red Hat and VMware for our portfolio. At the same time, our research led us to continue to overweight Amazon. Even though its market share in this area was going to be smaller than anticipated, the total market was larger than we expected, which benefited Amazon.

Our insights into what was going on in the cloud came from our ability to do customer surveys, to attend conferences, and to talk to many consultants and experts in the field. This story exemplifies the point that alpha generation comes from having the resources to do thorough research.

Important Information

This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, and prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. 

It is not intended for distribution to retail investors in any jurisdiction.

USA—Issued in the USA by T. Rowe Price Associates, Inc., 100 East Pratt Street, Baltimore, MD, 21202, which is regulated by the U.S. Securities and Exchange Commission. For Institutional Investors only.

© 2018 T. Rowe Price. All rights reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc.


Tap to dismiss


Latest Date Range
Audience for the document: Share Class: Language of the document:
Download Cancel


Share Class: Language of the document:
Download Cancel
Sign in to manage subscriptions for products, insights and email updates.
Continue with sign in?
To complete sign in and be redirected to your registered country, please select continue. Select cancel to remain on the current site.
Continue Cancel
Once registered, you'll be able to start subscribing.

Change Details

If you need to change your email address please contact us.
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price ("TRP") claims compliance with the Global Investment Performance Standards (GIPS®). TRP has been independently verified for the twenty one- year period ended June 30, 2017 by KPMG LLP. The verification report is available upon request. Verification assesses whether (1) the firm has complied with all the composite construction requirements of the GIPS standards on a firm-wide basis and (2) the firm's policies and procedures are designed to calculate and present performance in compliance with the GIPS standards. Verification does not ensure the accuracy of any specific composite presentation.

TRP is a U.S. investment management firm with various investment advisers registered with the U.S. Securities and Exchange Commission, the U.K. Financial Conduct Authority, and other regulatory bodies in various countries and holds itself out as such to potential clients for GIPS purposes. TRP further defines itself under GIPS as a discretionary investment manager providing services primarily to institutional clients with regard to various mandates, which include U.S, international, and global strategies but excluding the services of the Private Asset Management group.

A complete list and description of all of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest